FDA Commissioner Hamburg Makes First Trip to India

From DCAT Value Chain Insights (VCI)

By Regulatory News posted 02-10-2014 14:47

FDA Commissioner Margaret A. Hamburg, M.D. will travel Feb. 10-18 to India to further strengthen cooperation between the FDA and its Indian regulatory counterparts.

During the trip, which will include visits to Delhi, Cochin, and Mumbai, Commissioner Hamburg will meet . Currently, India is the second largest provider of finished drug products and the eighth largest exporter of food products to the United States, according to FDA.

“The FDA’s ongoing engagement with our regulatory counterparts in India is critical to our ability to effectively promote the health and safety of American and Indian consumers,” said Commissioner Hamburg in a press statement. “I look forward to enhancing our existing relationship and identifying additional opportunities for collaboration.”

The cooperation of United States and Indian food and drug officials is wide ranging, from sharing information on the conduct of clinical trials to jointly addressing product safety issues that may have an impact on both American and Indian consumers. Commissioner Hamburg will also meet with industry leaders in India to discuss the importance of maintaining high-quality standards in producing goods to ensure consumers have access to safe products.

This is Commissioner Hamburg’s first official trip to India.

Source: FDA

Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT). 

Learn more and sign up to receive a complimentary subscription